CCM
PFE icon

Coldstream Capital Management’s Pfizer PFE Stock Holding History

Coldstream Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.21M Sell
149,848
-111,007
-43% -$2.96M 0.05% 160
2025
Q4 		$6.5M Buy
260,855
+113,062
+77% +$2.85M 0.08% 129
2025
Q3 		$3.77M Buy
147,793
+31,497
+27% +$777K 0.05% 176
2025
Q2 		$2.82M Buy
116,296
+31,228
+37% +$728K 0.05% 210
2025
Q1 		$2.16M Sell
85,068
-142,255
-63% -$3.72M 0.05% 232
2024
Q4 		$6.03M Buy
227,323
+119,111
+110% +$3.23M 0.13% 103
2024
Q3 		$3.11M Buy
108,212
+13,535
+14% +$395K 0.07% 161
2024
Q2 		$2.65M Buy
94,677
+16,790
+22% +$462K 0.06% 154
2024
Q1 		$2.16M Buy
77,887
+6,813
+10% +$189K 0.05% 179
2023
Q4 		$2.05M Sell
71,074
-87,136
-55% -$2.63M 0.06% 172
2023
Q3 		$5.25M Sell
158,210
-4,992
-3% -$177K 0.17% 83
2023
Q2 		$5.99M Buy
163,202
+1,285
+0.8% +$50K 0.19% 79
2023
Q1 		$6.61M Sell
161,917
-5,148
-3% -$222K 0.22% 71
2022
Q4 		$8.56M Buy
+167,065
New +$8.01M 0.31% 49
2022
Q2 		$8.83M Buy
168,482
+12,855
+8% +$655K 0.34% 50
2022
Q1 		$8.06M Sell
155,627
-11,507
-7% -$597K 0.28% 57
2021
Q4 		$9.87M Buy
167,134
+53,109
+47% +$2.63M 0.31% 54
2021
Q3 		$4.18M Sell
114,025
-19,934
-15% -$883K 0.2% 70
2021
Q2 		$5.25M Buy
133,959
+2,194
+2% +$85.3K 0.21% 67
2021
Q1 		$4.77M Buy
131,765
+6,900
+6% +$245K 0.28% 54
2020
Q4 		$4.6M Buy
124,865
+13,108
+12% +$481K 0.28% 50
2020
Q3 		$3.89M Buy
111,757
+2,598
+2% +$91.1K 0.32% 48
2020
Q2 		$3.39M Buy
109,159
+937
+0.9% +$31.8K 0.3% 56
2020
Q1 		$3.35M Buy
108,222
+6,963
+7% +$237K 0.37% 44
2019
Q4 		$3.76M Buy
101,259
+10,046
+11% +$358K 0.31% 57
2019
Q3 		$3.11M Sell
91,213
-7,563
-8% -$275K 0.26% 68
2019
Q2 		$4.06M Buy
98,776
+390
+0.4% +$15.5K 0.34% 56
2019
Q1 		$3.96M Sell
98,386
-15,912
-14% -$637K 0.35% 55
2018
Q4 		$4.73M Buy
114,298
+4,923
+5% +$204K 0.46% 41
2018
Q3 		$4.57M Buy
109,375
+6,391
+6% +$246K 0.41% 42
2018
Q2 		$3.54M Buy
102,984
+2,535
+3% +$86.6K 0.36% 46
2018
Q1 		$3.38M Buy
100,449
+4,111
+4% +$141K 0.37% 47
2017
Q4 		$3.31M Buy
96,338
+4,233
+5% +$144K 0.36% 54
2017
Q3 		$3.12M Buy
92,105
+5,106
+6% +$164K 0.36% 56
2017
Q2 		$2.77M Buy
86,999
+7,631
+10% +$241K 0.36% 53
2017
Q1 		$2.58M Buy
79,368
+2,396
+3% +$75.5K 0.36% 49
2016
Q4 		$2.37M Buy
76,972
+57,382
+293% +$1.75M 0.39% 44
2016
Q3 		$630K Sell
19,590
-320
-2% -$10.7K 0.11% 106
2016
Q2 		$665K Buy
19,910
+614
+3% +$19.6K 0.12% 144
2016
Q1 		$543K Buy
19,296
+5,947
+45% +$170K 0.1% 114
2015
Q4 		$409K Sell
13,349
-118
-0.9% -$3.71K 0.09% 106
2015
Q3 		$401K Sell
13,467
-935
-6% -$30K 0.11% 105
2015
Q2 		$458K Buy
+14,402
New +$469K 0.12% 95
2015
Q1 		– Sell
-7,218
Closed -$213K – 166
2014
Q4 		$213K Buy
+7,218
New +$207K 0.06% 160

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Coldstream Capital Management's PFE Position: Q1 2026 in Review

Coldstream Capital Management reduced its Pfizer (PFE) stake by 43% in Q1 2026, selling an estimated $2.96M and leaving 149,848 shares worth $4.21M. The position accounts for 0.05% of the portfolio, ranked #160.

Coldstream Capital Management first reported a position in PFE in Q4 2014 and has held it in 44 quarters since. The position peaked at $9.87M in Q4 2021. 2,947 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Coldstream Capital Management held 149,848 shares of Pfizer worth $4.21M as of Q1 2026.
  • Coldstream Capital Management sold 111,007 Pfizer shares in Q1 2026, an estimated $2.96M.
  • Pfizer made up 0.05% of Coldstream Capital Management's portfolio in Q1 2026, its #160 holding.
  • Coldstream Capital Management first reported a position in Pfizer in Q4 2014 and has held it in 44 quarters since.
  • Coldstream Capital Management's Pfizer position peaked at $9.87M in Q4 2021.
  • 2,947 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.